Response to Dr. Wee

Affiliations

¹ Department of Neurology, Niguarda General Hospital, Milan, Italy.
² Department of Neuromuscular Disease, San Raffaele Hospital, Milan, Italy.
³ Department of Neuroscience, University of Turin, Torino, Italy.
⁴ Department of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Messina, Italy.
⁵ Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.
⁶ Department of Neuroscience, University Tor Vergata, Rome, Italy.
⁷ Department of Neuroscience, Mental Health and Sensory Organs, Rome University "Sapienza", Sant'Andrea Hospital, Rome, Italy.
⁸ Department of Neurology, Alesssandro Manzoni General Hospital, Lecco, Italy.

Comment

Stefano Jann et al. Pain Med. 2020.

. 2020 Oct 1;21(10):2604.

doi: 10.1093/pm/pnaa056.

¹ Department of Neurology, Niguarda General Hospital, Milan, Italy.
² Department of Neuromuscular Disease, San Raffaele Hospital, Milan, Italy.
³ Department of Neuroscience, University of Turin, Torino, Italy.
⁴ Department of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Messina, Italy.
⁵ Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.
⁶ Department of Neuroscience, University Tor Vergata, Rome, Italy.
⁷ Department of Neuroscience, Mental Health and Sensory Organs, Rome University "Sapienza", Sant'Andrea Hospital, Rome, Italy.
⁸ Department of Neurology, Alesssandro Manzoni General Hospital, Lecco, Italy.

No abstract available

Comment on

High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
Jann S, Fazio R, Cocito D, Toscano A, Schenone A, Marfia GA, Antonini G, De Toni Franceschini L, Mazzeo A, Grandis M, Velardo D, Mataluni G, Peci E. Jann S, et al. Pain Med. 2020 Mar 1;21(3):576-585. doi: 10.1093/pm/pnz331. Pain Med. 2020. PMID: 31904855 Clinical Trial.
High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments.
Wee TC, Tan YL. Wee TC, et al. Pain Med. 2020 Oct 1;21(10):2603-2604. doi: 10.1093/pm/pnaa057. Pain Med. 2020. PMID: 32196108 No abstract available.